Clinical Trials

Clinical trials and studies about imaging technology can be found on this channel.

New X-ray Technology Can Improve COVID-19 Diagnosis
December 7, 2022 — A research team at the Technical University of Munich (TUM) has, for the first time, produced dark-field X-ray images of patients infected with the…
Steroid Injections Worsen Knee Arthritis
November 29, 2022 — Two studies comparing injections commonly used to relieve the pain of knee osteoarthritis found that corticosteroid injections were associated with
Ultra-high-res MRI Reveals Migraine Brain Changes
November 23, 2022 — For the first time, a new study has identified enlarged
Drinking During Pregnancy Changes Baby’s Brain Structure
November 22, 2022 — A new MRI study revealed that consumption of alcohol even in low to m
VIDEO: Randomized Phase III Trial of Hypo Fractionated Whole Breast Irradiation with Concurrent Boost vs. Conventional Whole Breast Irradiation
Dr. Frank A.

PRISMA flow diagram shows identification, screening, and inclusion of studies

MRI Surveillance for Postsurgical Musculoskeletal Soft-Tissue Sarcomas

February 1, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), MRI ...

February 01, 2023

Study finds that Black patients and patients living in certain regions experience greater delays.

News | Breast Imaging

Race and Geography Linked to Different Risks of Breast Cancer Treatment Delays

January 24, 2023 — For patients with cancer, lengthy delays in treatment can decrease their chances of survival. In an ...

January 24, 2023

Deciphex, a Dublin-based software company focused on developing digital pathology-based software and services for clinical and research pathology, has announced the rollout of its Automated Image Quality Control (QC) for digital research pathology.

News | Digital Pathology

Digital Pathology Software Firm Deciphex Builds Automated Image QC into Research Platform

January 19, 2023 — In an effort to speed up the research study process, Deciphex has announced the rollout of its ...

January 19, 2023

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including leukemias, lymphomas and breast cancer. Anthracyclines — such as doxorubicin, frequently used against breast cancer — kill cancer cells by damaging their DNA. However, these effective chemotherapies also cause toxic effects in the heart in about ten percent of patients that can eventually lead to heart failure, particularly in older patients with pre-existing cardiovascular disease. Current

News | Breast Imaging

Researchers ID Protein that may Protect the Heart During Certain Cancer Treatment Regimens

December 29, 2022 — Anthracyclines are a class of chemotherapies effective in treating many forms of cancer, including ...

December 29, 2022

News | Lung Imaging

Study Suggests AI can Predict Risk of Lung Cancer Returning Using CT Scans

December 26, 2022 — Artificial intelligence (AI) could help identify the risk of cancer returning in non-small cell lung ...

December 26, 2022

An imaging agent just approved by the FDA will allow surgeons to identify additional cancerous lesions, which otherwise would have been left behind, in up to 24% more patients during non-small cell lung cancer surgery. Philip Low, Purdue University’s Presidential Scholar for Drug Discovery and the Ralph C. Corley Distinguished Professor of Chemistry, is an inventor of the foundational intellectual property upon which the drug is based.

News | Lung Imaging

Imaging Agent Illuminates Lung Cancer Tumors

December 21, 2022 — Surgery, especially surgery to remove cancerous tumors, relies on a range of tools and techniques as ...

December 21, 2022

Researchers reveal new noninvasive MRI measures of the glymphatic system function that could be used to track Alzheimer disease progression

News | Magnetic Resonance Imaging (MRI)

Impaired Glymphatic System May be Linked with Progression of Alzheimer's Disease, Finds New Study

December 19, 2022 — The glymphatic system is the waste clearing pathway of the human brain. It is speculated that an ...

December 19, 2022

data showed that CytoSite’s Granzyme B (GzmB) PET imaging using [68Ga-NOTA]-hGZP (CSB-111) was feasible and safe in human subjects. These data come from a Phase I trial assessing the safety and feasibility of GzmB PET imaging in subjects with melanoma and non-small cell lung cancer (NSCLC) receiving KEYTRUDA (pembrolizumab).

News | Clinical Trials

CytoSite Bio Presents First-in-Human Data at Radiological Society of North American Annual Meeting

December 14, 2022 — CytoSite Bio, a company developing precision imaging products that determine patient response to ...

December 14, 2022

Prof. Dr. Franz Pfeiffer (back, left), Professor for Biomedical Physics, and his team have developed a prototype of a clinical CT scanner which combines dark-field and conventional X-ray technology (back right: Dr. Thomas Koehler, front left: Clemens Schmid, front right: Manuel Viermetz).

News | Coronavirus (COVID-19)

New X-ray Technology Can Improve COVID-19 Diagnosis

December 7, 2022 — A research team at the Technical University of Munich (TUM) has, for the first time, produced dark ...

December 07, 2022

Three-dimensional segmentation of ginger-root shaped necrotic lesions (yellow) and surrounding vasculature (red) within a sample of Mycobacterium tuberculosis-infected human lung tissue (transparent surface). Africa Health Research Institute

News | Coronavirus (COVID-19)

Tuberculosis and COVID-19 Lung lesions Revealed by High-Resolution Three-Dimensional Imaging

December 7, 2022 — Gross anatomy reveals three-dimensional shapes of pathology at a large scale. Histology, in contrast ...

December 07, 2022

A presentation during the Radiological Society of North America Scientific Session and Annual Meeting (RSNA 2022) featured IceCure Medical Ltd. and its minimally-invasive cryoablation technology, addressing Increasing interest among breast and interventional radiologists in performing breast tumor cryoablation.

News | RSNA

IceCure Medical Features Tumor Cryoablation Technology at RSNA 2022

December 9, 2022 — A poster presentation during the Radiological Society of North America Scientific Session and Annual ...

December 07, 2022

18F-rhPSMA-7.3 PET image showing multiple areas of uptake in the prostate gland in a man with newly diagnosed prostate cancer Photo courtesy of Blue Earth Diagnostics

News | Prostate Cancer

Blue Earth Diagnostics Announces Efficacy and Safety Results from Phase 3 LIGHTHOUSE Trial of Investigational PET Imaging Agent 18F-rhPSMA-7.3 in Newly Diagnosed Prostate Cancer

December 2, 2022 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

December 02, 2022

A team led by UTHealth Houston's K. Lance Gould, MD, (center) used PET imaging technology (shown above) to map coronary blood flow and its outcomes among heart disease patients. (Photo by UTHealth Houston)

News | PET Imaging

PET Technology More Effective Than Angiogram at Determining Need for Coronary Stents, Bypass Surgery

December 1, 2022 — A new method for determining whether patients with heart disease need coronary stents or bypass ...

December 01, 2022

Annalise.ai and Nuance announced that the global medical imaging AI company has joined the Nuance Precision Imaging Network (PIN), connecting Annalise.ai workflow orchestration and diagnostic support solutions to over 12,000 healthcare facilities worldwide.

News | Artificial Intelligence

VIDA Launches VIDA Intelligence Portal 2.0 to Accelerate Onboarding of Clinical Trial Sites

December 1, 2022 — VIDA Diagnostics, Inc. (VIDA), the leader in imaging intelligence, has announced the availability of ...

December 01, 2022

Figure 1. Knee joint of a patient showing (A) severe cartilage defects and (B) intact knee joint.

News | Magnetic Resonance Imaging (MRI)

Steroid Injections Worsen Knee Arthritis

November 29, 2022 — Two studies comparing injections commonly used to relieve the pain of knee osteoarthritis found that ...

November 29, 2022

Figure 3. A 3D map of centrum semiovale (CSO) and basal ganglia (BG) perivascular spaces (PVS) generated from physician-reviewed automated segmentation of PVS using ITK-SNAP software.

News | Magnetic Resonance Imaging (MRI)

Ultra-high-res MRI Reveals Migraine Brain Changes

November 23, 2022 — For the first time, a new study has identified enlarged perivascular spaces in the brains of ...

November 23, 2022

Figure 1. Left: Fetal brain post-intrauterine alcohol exposure in fetus between 25 and 29 gestational weeks. Note the smooth cortex in frontoparietal and temporal lobes. Right: Brain of matched healthy control case in fetus between 25 and 28 gestational weeks. The superior temporal sulcus is already bilaterally formed (red arrows) and appears deeper on the right hemisphere than on the left.

News | Pediatric Imaging

Drinking During Pregnancy Changes Baby’s Brain Structure

November 22, 2022 — A new MRI study revealed that consumption of alcohol even in low to moderate amounts during ...

November 22, 2022

71-year-old woman at high-risk for HCC due to chronic hepatitis B. Patient underwent CEUS using perfluorobutane. (A) Arterial-phase CEUS image (12 seconds after injection) shows 25-mm segment-8 lesion with nonrim hyperenhancement (arrow). (B) CEUS image in portal-venous phase (48 seconds) shows corresponding early washout (arrow). (C) CEUS image in late phase (2 minutes) shows corresponding late and mild washout (arrow). (D) CEUS image in Kupffer phase (15 minutes) shows marked Kupffer defect (arrow). Patie

News | Magnetic Resonance Imaging (MRI)

CEUS With Perfluorobutane Diagnoses High-Risk HCC

November 17, 2022 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR) ...

November 17, 2022

Videos | ASTRO

VIDEO: Randomized Phase III Trial of Hypo Fractionated Whole Breast Irradiation with Concurrent Boost vs. Conventional Whole Breast Irradiation

Dr. Frank A. Vicini, MD, FACR, FASTRO, FABS, who is a radiation oncologist with GenesisCare, discussed his findings from ...

November 09, 2022

News | Radiation Therapy

ViewRay Launches Phase III Pancreatic Cancer Study to Demonstrate Superior Overall Survival for Patients Receiving MRI-guided Ablative Radiation Therapy

November 2, 2022 — ViewRay, Inc. announced the launch of a phase III randomized controlled trial titled "Locally ...

November 02, 2022